Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Galena Biopharma Company Profile (NASDAQ:GALE)

Consensus Ratings for Galena Biopharma (NASDAQ:GALE) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $4.64 (241.39% upside)

Analysts' Ratings History for Galena Biopharma (NASDAQ:GALE)
Show:
DateFirmActionRatingPrice TargetActions
5/22/2015Roth CapitalReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015ZacksUpgradeHold -> Buy$1.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015ZacksDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Maxim GroupReiterated RatingBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015MLV & Co.Set Price TargetBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2015Noble FinancialReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Needham & Company LLCSet Price TargetBuy$7.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Cantor FitzgeraldSet Price TargetSell$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2015MLV & Co.Set Price TargetBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/16/2015Maxim GroupSet Price TargetBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014MLV & Co.Boost Price TargetBuy$3.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014Roth CapitalReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2014Cantor FitzgeraldReiterated RatingSell$2.25 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2014MLV & Co.Reiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/22/2014MLV & Co.Lower Price TargetBuy$5.00 -> $3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2014Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2014Needham & Company LLCLower Price TargetBuy$9.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2014Roth CapitalBoost Price Target$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Noble FinancialReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2014MLV & Co.Lower Price Target$6.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2014Roth CapitalLower Price Target$12.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2014Cantor FitzgeraldDowngradeSell$3.50 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2014Cantor FitzgeraldDowngradeBuy -> Sell$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2014Noble FinancialBoost Price TargetBuy$4.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2014Maxim GroupBoost Price TargetBuy$9.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2014Needham & Company LLCBoost Price Target$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/14/2014Roth CapitalBoost Price Target$11.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2014Maxim GroupBoost Price TargetBuy$6.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2013OppenheimerInitiated CoverageOutperform$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2013 forward)